[go: up one dir, main page]

PE20121648A1 - Procedimiento de identificacion de animales vacunados frente a brucella - Google Patents

Procedimiento de identificacion de animales vacunados frente a brucella

Info

Publication number
PE20121648A1
PE20121648A1 PE2012000760A PE2012000760A PE20121648A1 PE 20121648 A1 PE20121648 A1 PE 20121648A1 PE 2012000760 A PE2012000760 A PE 2012000760A PE 2012000760 A PE2012000760 A PE 2012000760A PE 20121648 A1 PE20121648 A1 PE 20121648A1
Authority
PE
Peru
Prior art keywords
brucella
identification
procedure
gfp
vaccinated animals
Prior art date
Application number
PE2012000760A
Other languages
English (en)
Inventor
Dolset Maria Grillo
Zabalza Beatriz Amorena
Andres Cara Damian De
Robles Edgardo Moreno
Olarte Esteban Chaves
Verri Caterina Guzman
Diaz Carlos Chacon
Original Assignee
Consejo Superior Investigacion
Univ Nac De Costa Rica Una
Univ De Costa Rica Ucr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior Investigacion, Univ Nac De Costa Rica Una, Univ De Costa Rica Ucr filed Critical Consejo Superior Investigacion
Publication of PE20121648A1 publication Critical patent/PE20121648A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43595—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/098—Brucella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/23—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Brucella (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43595—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from coelenteratae, e.g. medusae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

SE REFIERE A UNA COMPOSICION QUE ES UNA VACUNA QUE COMPRENDE UNA CEPA DE BRUCELLA SPP TAL COMO BRUCELLA ABORTUS S19 O BRUCELLA MELITENSIS REV 1 QUE EXPRESA LA PROTEINA GREEN FLOURESCENT PROTEIN (GFP) QUE ES UTIL EN LA PREVENCION DE BRUCELOSIS EN MAMIFEROS RUMIANTES DE LA SUBFAMILIA BOVINAE O CAPRINAE. TAMBIEN SE REFIERE A UN METODO PARA IDENTIFICAR LOS MAMIFEROS TRATADOS CON DICHA VACUNA QUE COMPRENDE A) OBTENER UNA MUESTRA BIOLOGICA AISLADA DEL MAMIFERO TAL COMO CELULAS O TEJIDOS, Y B) DETECTAR LA PRESENCIA DEL GEN gfp O DE LOS PRODUCTOS DE SU EXPRESION EN LA MUESTRA BIOLOGICA MEDIANTE LA DETECCION DE LOS ANTICUERPOS ANTI-GFP CON UN INMUNOENSAYO
PE2012000760A 2009-12-03 2010-11-29 Procedimiento de identificacion de animales vacunados frente a brucella PE20121648A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200931101A ES2372187B8 (es) 2009-12-03 2009-12-03 Procedimiento de identificación de animales vacunados frente a brucella.

Publications (1)

Publication Number Publication Date
PE20121648A1 true PE20121648A1 (es) 2012-12-24

Family

ID=44114638

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2012000760A PE20121648A1 (es) 2009-12-03 2010-11-29 Procedimiento de identificacion de animales vacunados frente a brucella

Country Status (7)

Country Link
EP (1) EP2508201A4 (es)
CN (1) CN102781468A (es)
CR (1) CR20120301A (es)
ES (1) ES2372187B8 (es)
MX (1) MX2012006303A (es)
PE (1) PE20121648A1 (es)
WO (1) WO2011067446A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019101993A1 (en) 2017-11-24 2019-05-31 Consejo Superior De Investigaciones Científicas (Csic) A modified brucella vaccine strain for the treatment of brucellosis
CN110863031A (zh) * 2019-09-29 2020-03-06 安徽医科大学第一附属医院 一种检测布鲁菌病治疗效果的标志物及其应用
CN111796091B (zh) * 2020-07-20 2023-09-08 天康生物制药有限公司 用于区分动物感染布氏杆菌或布氏杆菌菌影疫苗的试剂盒
WO2022271201A2 (en) * 2021-01-07 2022-12-29 International Advantage, Inc. Ace2 and tmprss2 gene expression as predictive markers of covid-19 severity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7416878B2 (en) * 2002-12-12 2008-08-26 The United States Of America As Represented By The Secretary Of The Army Immunogenic compositions including rough phenotype Brucella host strains and complementation DNA fragments
CN101240290B (zh) * 2008-02-29 2011-06-15 杭州师范大学 一种含绿色荧光蛋白基因的植物转基因表达载体及其构建方法和应用
US20100226942A1 (en) * 2008-10-30 2010-09-09 Schurig Gerhardt G Producing an immune response for reducing the risk of developing brucellosis
CN101586120B (zh) * 2009-07-15 2011-06-15 中国农业科学院哈尔滨兽医研究所 狂犬病病毒Flury-LEP疫苗株反向遗传操作系统及LEP绿色荧光蛋白重组病毒载体

Also Published As

Publication number Publication date
ES2372187A1 (es) 2012-01-17
MX2012006303A (es) 2012-09-07
WO2011067446A1 (es) 2011-06-09
CN102781468A (zh) 2012-11-14
EP2508201A4 (en) 2013-08-07
ES2372187B8 (es) 2013-04-29
CR20120301A (es) 2013-02-27
EP2508201A1 (en) 2012-10-10
ES2372187B1 (es) 2012-11-26

Similar Documents

Publication Publication Date Title
Roeber et al. The specific diagnosis of gastrointestinal nematode infections in livestock: larval culture technique, its limitations and alternative DNA-based approaches
CL2013002907A1 (es) Acido nucleico aislado del virus de peces prv; polipeptido aislado; anticuerpo que se une a dicho polipeptido; metodo para determinar la presencia o ausencia de prv en una muestra biologica; arn interferente; y uso para reducir los niveles de proteina viral en una celula de un animal (div.sol.n°822-12).
EA200971124A1 (ru) Множественный анализ образцов крови
Schatz et al. Twenty years of active bat rabies surveillance in Germany: a detailed analysis and future perspectives
BR122018069446B8 (pt) método in vitro para detectar a presença de um célula de câncer em um indivíduo
ES2528321T3 (es) Detección de a-fucosilación en anticuerpos
MX2012001000A (es) Metodo y kit para la deteccion de un microorganismo.
PE20131062A1 (es) Uso de hmgb1 como marcador biologico de afecciones intestinales inflamatorias, metodo no invasivo para su deteccion en muestras fecales y kit para su realizacion
BR112012016119A2 (pt) detecção de carga biológica viva com o uso de micropartículas
BR112016009460A8 (pt) método para detectar a presença de anticorpos neutralizantes, e, kit
BRPI0915619A2 (pt) métodos para determinar uma probabilidade de que um sujeito tenha contribuído com material genético para amostra de teste de material genético, para caracterizar amostra de teste de material genético e para determinar se uma pessoa de interesse contribuiu com material genético para uma amostra de teste de material genético, kit para análise de amostra de teste de material genético e sistema para determinar se um sujeito contribuiu com material genético para uma amostra
CR9635A (es) Deteccion de un antigeno diana independientemente de la presencia o ausencia de un anticuerpo terapeutico correspondiente
ES2570731T3 (es) Método de detección de cáncer
BR112013001845B8 (pt) Dispositivo adequado para coleta de amostras de um fluído da cavidade bucal de um mamífero e método para coletar e analisar uma amostra de um fluído da cavidade bucal de um mamífero
BRPI1007867B8 (pt) anticorpo recombinante ou fragmento de ligação ao antígeno do mesmo, composição farmacêutica e kit compreendendo o referido anticorpo, métodos de detecção de antígeno de troponina i em uma amostra de teste e métodos in vitro de diagnóstico de síndrome coronariana aguda ou infarto do miocárdio em um paciente
AR078423A1 (es) Vacunas dirigidas a las celulas de langerhans
ES2479542T1 (es) Métodos y composiciones para su uso en terapias celulares
CO6710946A2 (es) Método para activar células t auxiliares
AR071220A1 (es) Astrovirus aviario depositado bajo el nuero cncm i-3895
EA201892663A1 (ru) Аналоги фосфолипидного эфира для идентификации и выделения циркулирующих опухолевых клеток
PE20141565A1 (es) Metodos para detectar papilomavirus humano y proporcionar pronostico para carcinoma de celulas escamosas de cabeza y cuello
WO2009023331A3 (en) Antibodies and improved test sample handling methods for use in assays for myeloperoxidase
MX2014011504A (es) Metodos para la deteccion de anticuerpos neutralizantes anticitomegalovirus.
ES2638294T3 (es) Método de detección de cáncer
PE20121648A1 (es) Procedimiento de identificacion de animales vacunados frente a brucella

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed